These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35091008)

  • 1. QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction.
    Boitard SE; Keck M; Deloux R; Girault-Sotias PE; Marc Y; De Mota N; Compere D; Agbulut O; Balavoine F; Llorens-Cortes C
    Can J Cardiol; 2022 Jun; 38(6):815-827. PubMed ID: 35091008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
    Boitard SE; Marc Y; Keck M; Mougenot N; Agbulut O; Balavoine F; Llorens-Cortes C
    J Mol Cell Cardiol; 2019 Feb; 127():215-222. PubMed ID: 30599150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction.
    Leenen FHH; Ahmad M; Marc Y; Llorens-Cortes C
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):82-91. PubMed ID: 30531435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.
    Marc Y; Boitard SE; Balavoine F; Azizi M; Llorens-Cortes C
    Can J Cardiol; 2020 May; 36(5):721-731. PubMed ID: 32389345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
    Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction.
    Ruetten H; Gehring D; Hiss K; Schindler U; Gerl M; Busch AE; Schaefer S
    Br J Pharmacol; 2005 Nov; 146(5):723-31. PubMed ID: 16151439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
    Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
    Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Pro)renin Receptor Blockade Ameliorates Cardiac Injury and Remodeling and Improves Function After Myocardial Infarction.
    Ellmers LJ; Rademaker MT; Charles CJ; Yandle TG; Richards AM
    J Card Fail; 2016 Jan; 22(1):64-72. PubMed ID: 26362519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
    Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
    Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
    Sandmann S; Bohle RM; Dreyer T; Unger T
    Virchows Arch; 2000 Feb; 436(2):147-57. PubMed ID: 10755606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.
    Cittadini A; Monti MG; Isgaard J; Casaburi C; Strömer H; Di Gianni A; Serpico R; Saldamarco L; Vanasia M; Saccà L
    Cardiovasc Res; 2003 Jun; 58(3):555-64. PubMed ID: 12798428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
    Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.
    Alghamri MS; Morris M; Meszaros JG; Elased KM; Grobe N
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1032-40. PubMed ID: 24464749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.
    von Lueder TG; Wang BH; Kompa AR; Huang L; Webb R; Jordaan P; Atar D; Krum H
    Circ Heart Fail; 2015 Jan; 8(1):71-8. PubMed ID: 25362207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.